A Phase II, Randomized, Double-blind, Placebo-controlled Study of a Controlled Release Minicapsule Formulation of Ciclosporin (CyCol) in the Treatment of Mild to Moderate Ulcerative Colitis.

Trial Profile

A Phase II, Randomized, Double-blind, Placebo-controlled Study of a Controlled Release Minicapsule Formulation of Ciclosporin (CyCol) in the Treatment of Mild to Moderate Ulcerative Colitis.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Sep 2014

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Apr 2012 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
    • 18 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Mar 2012 The trial status is completed in (Ireland) as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top